- Home
- CRL vs MKTX Comparison
CRL vs MKTX Comparison
Compare CRL & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- MKTX
- Stock Information
- Founded
- CRL 1947
- MKTX 2000
- Country
- CRL United States
- MKTX United States
- Employees
- CRL N/A
- MKTX N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- MKTX Investment Bankers/Brokers/Service
- Sector
- CRL Health Care
- MKTX Finance
- Exchange
- CRL Nasdaq
- MKTX Nasdaq
- Market Cap
- CRL 7.3B
- MKTX 8.1B
- IPO Year
- CRL 2000
- MKTX 2004
- Fundamental
- Price
- CRL $156.68
- MKTX $190.04
- Analyst Decision
- CRL Buy
- MKTX Hold
- Analyst Count
- CRL 14
- MKTX 10
- Target Price
- CRL $186.00
- MKTX $229.70
- AVG Volume (30 Days)
- CRL 1.1M
- MKTX 584.9K
- Earning Date
- CRL 08-06-2025
- MKTX 08-06-2025
- Dividend Yield
- CRL N/A
- MKTX 1.60%
- EPS Growth
- CRL N/A
- MKTX N/A
- EPS
- CRL N/A
- MKTX 5.95
- Revenue
- CRL $4,028,615,000.00
- MKTX $837,157,000.00
- Revenue This Year
- CRL N/A
- MKTX $8.07
- Revenue Next Year
- CRL $2.49
- MKTX $9.87
- P/E Ratio
- CRL N/A
- MKTX $31.92
- Revenue Growth
- CRL N/A
- MKTX 7.67
- 52 Week Low
- CRL $91.86
- MKTX $183.00
- 52 Week High
- CRL $230.02
- MKTX $296.68
- Technical
- Relative Strength Index (RSI)
- CRL 47.73
- MKTX 34.64
- Support Level
- CRL $145.99
- MKTX $187.05
- Resistance Level
- CRL $168.61
- MKTX $192.29
- Average True Range (ATR)
- CRL 5.10
- MKTX 4.97
- MACD
- CRL -1.68
- MKTX -0.99
- Stochastic Oscillator
- CRL 31.41
- MKTX 25.20
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.